Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H30O5 |
Molecular Weight | 350.4492 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCC(=O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
InChI
InChIKey=YRTJDWROBKPZNV-KMXMBPPJSA-N
InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,16-17,19,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t16-,17-,19-/m1/s1
Molecular Formula | C20H30O5 |
Molecular Weight | 350.4492 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 2 |
Optical Activity | UNSPECIFIED |
15-Ketoprostaglandin E2 (15-keto PGE2) is a metabolite of prostaglandin E2 (PGE2) with reduced biological activity, which then by the action of prostaglandin reductase 2 (PTGR2) transforms into 13,14-dihydro-15-keto-PGE2, s a secondary metabolite without biological activity. Some experiments have shown that exists the therapeutic potential by targeting PTGR2/15-keto-PGE2 in pancreatic cancer. Besides, it is known, that 15-keto-PGE2 has higher affinity to the prostaglandin EP2 receptor than to the EP4 receptor. Some experiments also have revealed the key signaling cascade: 15-Hydroxyprostaglandin dehydrogenase (15-PGDH)/15-keto-PGE2-mediated activation of PPARγ and p21(WAF1/Cip1) in the regulation of the hepatocarcinogenesis and tumor progression.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P43116 Gene ID: 5732.0 Gene Symbol: PTGER2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/29175486 |
|||
Target ID: P37231|||Q15179 Gene ID: 5468.0 Gene Symbol: PPARG Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/23542179 |
|||
Target ID: Q8N8N7 Gene ID: 145482.0 Gene Symbol: PTGR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/26820738 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Albumin-eicosanoid interactions. A model system to determine their attributes and inhibition. | 1984 Mar 10 |
|
Quantitative high-performance liquid chromatography/electrospray ionization tandem mass spectrometric analysis of 2- and 3-series prostaglandins in cultured tumor cells. | 2002 Sep 1 |
|
Chinese hamster monomeric carbonyl reductases of the short-chain dehydrogenase/reductase superfamily. | 2009 Mar 16 |
|
A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules. | 2010 Jul 16 |
|
Modulation of nitro-fatty acid signaling: prostaglandin reductase-1 is a nitroalkene reductase. | 2013 Aug 30 |
|
15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids. | 2015 Feb 27 |
|
Human prostaglandin reductase 1 (PGR1): Substrate specificity, inhibitor analysis and site-directed mutagenesis. | 2015 Jun 5 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23542179
15-keto-prostaglandin E2 (15-keto-PGE2) induces p21WAF1/Cip1 gene transcription through PPAR gamma. Accordingly, treatment of the wild type Huh7 cells with 15-keto-PGE2 (10µM) significantly enhanced the p21 promoter reporter activity and this effect was abolished by PGR2 overexpression or GW9662 treatment (10µM). Treatment of wild type Huh7 cells with 15-keto-PGE2 (10µM) also enhanced PPAR gamma association with the p21 promoter DNA and the effect was blocked by the PPAR gamma antagonist GW9662 (10µM). Treatment of wild type Huh7 cells with the pharmacologic PPAR gamma agonist, ciglitazone, also increased PPAR gamma association with the p21 promoter. These observations demonstrate that 15-PGDH-derived 15-keto-PGE2 induces PPAR gamma association with the p21 promoter and enhances p21 transcription in hepatocellular carcinoma (HCC) cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 06:31:09 GMT 2023
by
admin
on
Sat Dec 16 06:31:09 GMT 2023
|
Record UNII |
2S0F1FTK13
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
57400
Created by
admin on Sat Dec 16 06:31:09 GMT 2023 , Edited by admin on Sat Dec 16 06:31:09 GMT 2023
|
PRIMARY | |||
|
2S0F1FTK13
Created by
admin on Sat Dec 16 06:31:09 GMT 2023 , Edited by admin on Sat Dec 16 06:31:09 GMT 2023
|
PRIMARY | |||
|
DTXSID401317991
Created by
admin on Sat Dec 16 06:31:09 GMT 2023 , Edited by admin on Sat Dec 16 06:31:09 GMT 2023
|
PRIMARY | |||
|
26441-05-4
Created by
admin on Sat Dec 16 06:31:09 GMT 2023 , Edited by admin on Sat Dec 16 06:31:09 GMT 2023
|
PRIMARY | |||
|
15547
Created by
admin on Sat Dec 16 06:31:09 GMT 2023 , Edited by admin on Sat Dec 16 06:31:09 GMT 2023
|
PRIMARY | |||
|
5280719
Created by
admin on Sat Dec 16 06:31:09 GMT 2023 , Edited by admin on Sat Dec 16 06:31:09 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
UNSPECIFIED
EP
|